Drug Profile
Balaglitazone
Alternative Names: DRF 2593Latest Information Update: 13 Aug 2015
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Developer Dr Reddys Laboratories; Rheoscience
- Class Antihyperglycaemics; Small molecules; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus